Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Cellular and Molecular Neurobiology
|
June 27, 2003
P2Y6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis
Seong G Kim, Zhan-Guo Gao, Kelly A Soltysiak, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 31, 2001
Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings
G Ravi, K Lee, X Ji, et al.
Medicine
|
January 5, 2019
Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report
Sebastian Burgos, Guillermo Montalban-Bravo, Lucia Fuente, et al.
Leukemia & Lymphoma
|
February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents
Kelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.
Cancer
|
November 20, 2019
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia
Koji Sasaki, Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, et al.
Leukemia & Lymphoma
|
September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia
Yue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Leukemia Research
|
September 25, 2018
Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation
Yasmin Abaza, Juliana E Hidalgo-Lopez, Srdan Verstovsek, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2021
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome
Kiyomi Morita, Elias Jabbour, Farhad Ravandi, et al.
Leukemia
|
November 14, 2019
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes
Guillermo Montalban-Bravo, Caleb A Class, Irene Ganan-Gomez, et al.
Leukemia
|
June 13, 2022
Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemia
Yue Wei, Rashmi Kanagal-Shamanna, Hong Zheng, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Cellular and Molecular Neurobiology
|
June 27, 2003
P2Y6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis
Seong G Kim, Zhan-Guo Gao, Kelly A Soltysiak, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 31, 2001
Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings
G Ravi, K Lee, X Ji, et al.
Medicine
|
January 5, 2019
Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report
Sebastian Burgos, Guillermo Montalban-Bravo, Lucia Fuente, et al.
Leukemia & Lymphoma
|
February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents
Kelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.
Cancer
|
November 20, 2019
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia
Koji Sasaki, Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, et al.
Leukemia & Lymphoma
|
September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia
Yue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Leukemia Research
|
September 25, 2018
Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation
Yasmin Abaza, Juliana E Hidalgo-Lopez, Srdan Verstovsek, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2021
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome
Kiyomi Morita, Elias Jabbour, Farhad Ravandi, et al.
Leukemia
|
November 14, 2019
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes
Guillermo Montalban-Bravo, Caleb A Class, Irene Ganan-Gomez, et al.
Leukemia
|
June 13, 2022
Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemia
Yue Wei, Rashmi Kanagal-Shamanna, Hong Zheng, et al.
Page
of 5